13F
中

NBIX NEUROCRINE BIOSCIENCES INC

2026Q1 · CUSIP 64125C109 · Sector: Healthcare & Biotech

Fading · Price holds, watch
Holders
691
Δ holders QoQ
-35
Breadth percentile
Top 96%
Whale holders
263
Δ whales
-8
Inst. holding value
$12.4B
New positions
86
Closed positions
121
Price momentum (1Q)
+23.1%
Put / Call
8/9

Breadth history (34 quarters)

2018Q1: Δ+1 · h=265 2018Q2: Δ+4 · h=269 2018Q3: Δ+68 · h=337 2018Q4: Δ-14 · h=323 2019Q1: Δ-4 · h=319 2019Q2: Δ-21 · h=298 2019Q3: Δ+34 · h=332 2019Q4: Δ+58 · h=390 2020Q1: Δ-25 · h=365 2020Q2: Δ+50 · h=415 2020Q3: Δ+0 · h=415 2020Q4: Δ-13 · h=402 2021Q1: Δ+12 · h=414 2021Q2: Δ-13 · h=401 2021Q3: Δ-11 · h=390 2021Q4: Δ+14 · h=404 2022Q1: Δ+17 · h=421 2022Q2: Δ+8 · h=429 2022Q3: Δ+32 · h=461 2022Q4: Δ+69 · h=530 2023Q1: Δ-43 · h=487 2023Q2: Δ-35 · h=452 2023Q3: Δ+61 · h=513 2023Q4: Δ+40 · h=553 2024Q1: Δ+33 · h=586 2024Q2: Δ+6 · h=592 2024Q3: Δ-23 · h=569 2024Q4: Δ+29 · h=598 2025Q1: Δ-13 · h=585 2025Q2: Δ+0 · h=585 2025Q3: Δ+61 · h=646 2025Q4: Δ+80 · h=726 2026Q1: Δ-35 · h=691 2018Q1: holders=265 2018Q2: holders=269 2018Q3: holders=337 2018Q4: holders=323 2019Q1: holders=319 2019Q2: holders=298 2019Q3: holders=332 2019Q4: holders=390 2020Q1: holders=365 2020Q2: holders=415 2020Q3: holders=415 2020Q4: holders=402 2021Q1: holders=414 2021Q2: holders=401 2021Q3: holders=390 2021Q4: holders=404 2022Q1: holders=421 2022Q2: holders=429 2022Q3: holders=461 2022Q4: holders=530 2023Q1: holders=487 2023Q2: holders=452 2023Q3: holders=513 2023Q4: holders=553 2024Q1: holders=586 2024Q2: holders=592 2024Q3: holders=569 2024Q4: holders=598 2025Q1: holders=585 2025Q2: holders=585 2025Q3: holders=646 2025Q4: holders=726 2026Q1: holders=691 -80 -40 +0 +40 +80 238501763 18Q119Q120Q121Q122Q123Q124Q125Q126Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 14 lit events

Period Percentile Next-1Q return Next-2Q return
2025Q4 Top 5% +23.1% —
2025Q3 Top 3% -9.4% +7.7%
2024Q4 Top 18% +7.8% +16.5%
2024Q1 Top 8% +4.2% -17.5%
2023Q4 Top 13% +7.5% +12.0%
2023Q3 Top 1% +22.0% +30.2%
2022Q4 Top 4% -7.7% +4.1%
2022Q3 Top 2% -8.1% -16.5%

Options Sentiment

Put holders
8
QoQ: 0
Call holders
9
QoQ: -2

See methodology →

Fundamentals

PE (TTM)
26.4
EPS (TTM)
$6.50
EPS YoY
+120.3%
Revenue (TTM)
$3.1B
Revenue YoY
+28.6%
Quarterly Revenue & EPS (4Y)
2022-06-30: $378M 2022-09-30: $388M 2022-12-31: $412M 2023-03-31: $420M 2023-06-30: $453M 2023-09-30: $499M 2023-12-31: $515M 2024-03-31: $515M 2024-06-30: $590M 2024-09-30: $622M 2024-12-31: $628M 2025-03-31: $573M 2025-06-30: $688M 2025-09-30: $795M 2025-12-31: $806M 2026-03-31: $815M 2022-06-30: EPS -0.18 2022-09-30: EPS 0.69 2022-12-31: EPS 0.91 2023-03-31: EPS -0.79 2023-06-30: EPS 0.95 2023-09-30: EPS 0.82 2023-12-31: EPS 1.49 2024-03-31: EPS 0.42 2024-06-30: EPS 0.63 2024-09-30: EPS 1.24 2024-12-31: EPS 1.00 2025-03-31: EPS 0.08 2025-06-30: EPS 1.06 2025-09-30: EPS 2.04 2025-12-31: EPS 1.49 2026-03-31: EPS 1.91 0M 407M 815M $M -0.87 0.69 2.24 20222023202420252026 Revenue EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time
4Y median 39 2023-03-31: PE 151.22023-06-30: PE 60.22023-09-30: PE 57.62023-12-31: PE 53.62024-03-31: PE 38.72024-06-30: PE 43.22024-09-30: PE 31.12024-12-31: PE 352025-03-31: PE 412025-06-30: PE 39.32025-09-30: PE 34.72025-12-31: PE 26.62026-03-31: PE 24.4 22 90 159 20222023202420252026

P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden

As of 2026-03-31 · SEC filings (XBRL)